You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Relevance of Salvage Treatment for Colorectal

Completed
  • Rectal Neoplasms
  • Neuroendocrine Tumors
  • salvage treatment
  • (no location specified)
Nov 16, 2023

Neuroendocrine Tumors Trial in Hyderabad (Endoscopic submucosal dissection, EFTR)

Recruiting
  • Neuroendocrine Tumors
  • Endoscopic submucosal dissection
  • EFTR
  • Hyderabad, Telangana, India
    Asian institute of Gastroenterology
Nov 11, 2023

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Neuroendocrine Tumors Trial in Beijing (Surufatinib Combined With Temozolomide and S-1)

Not yet recruiting
  • Neuroendocrine Tumors
  • Surufatinib Combined With Temozolomide and S-1
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 8, 2023

Surufatinib in G3 Neuroendocrine Tumors

Not yet recruiting
  • Neuroendocrine Tumor Grade 3
  • (no location specified)
Aug 2, 2023

Imaging Features in Invasiveness and Prognosis of Pituitary

Recruiting
  • Pituitary Adenoma
  • Neuroendocrine Tumors
  • diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
  • Guangzhou, Guangdong, China
    endocrinology department of the first affiliated hospital of Sun
Aug 24, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Multi-dimensional Fragmentomic Assay for Early Detection of

Not yet recruiting
  • Pancreatic Neuroendocrine Tumor
  • Fragmentomic profiles of plasma cfDNA
  • (no location specified)
Apr 27, 2023

Neuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor Trial in Madison (Single Photon Emission Computed

Not yet recruiting
  • Neuroendocrine Tumors
  • Somatostatin Receptor-positive Neuroendocrine Tumor
  • Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Nov 2, 2023

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • [212Pb] VMT-α-NET
  • [203Pb] VMT-α-NET SPECT/CT
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023

Neuroendocrine Tumors, Well-Differentiated Neuroendocrine Carcinoma, High Grade Neuroendocrine Carcinoma, Any Site Trial in San

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2023

Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

Completed
  • Pancreatic Neuroendocrine Tumor G2
  • Octreotide LAR
  • (no location specified)
Oct 17, 2023

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

Recruiting
  • VHL Pancreatic Neuroendocrine Tumors
  • +2 more
  • 68-Gallium DOTATATE
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Cancer Trial in Tampa (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023

Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)

Recruiting
  • Neuroendocrine Tumors
  • Al18F-NOTA-LM3
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Sep 20, 2023

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Not yet recruiting
  • Neuroendocrine Tumors
    • San Francisco, California
      Power Life Sciences
    Jul 21, 2023

    Collect Somatuline® Injector Device Preferences of Patients

    Not yet recruiting
    • Neuroendocrine Tumors
      • (no location specified)
      Jun 19, 2023

      68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors

      Recruiting
      • Neuroendocrine Tumors (NET)
      • 68Ga-HA-DOTATATE PET/CT imaging
      • Calgary, Alberta, Canada
        Foothills Medical Center 1403 29 St NW
      Jan 4, 2023

      Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

      Not yet recruiting
      • Advanced Gastroenteropancreatic Neuroendocrine Tumor
      • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
      • long-acting Octreotide.
      • (no location specified)
      May 22, 2023

      Neuroendocrine Tumors Trial in Lexington (Telotristat (Low-Dose), Telotristat (High-Dose))

      Recruiting
      • Neuroendocrine Tumors
      • Telotristat (Low-Dose)
      • Telotristat (High-Dose)
      • Lexington, Kentucky
        Markey Cancer Center
      Nov 10, 2022

      Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

      Not yet recruiting
      • Digestive System Neuroendocrine Tumor G1
      • +5 more
      • Tumor Debulking
      • +5 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Aug 23, 2023

      Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • +6 more
      • (no location specified)
      Aug 4, 2023

      Right-sided Hemicolectomy for Chldren With High-risk

      Recruiting
      • Neoplasms
      • Appendix Cancer
        • Amsterdam-Zuidoost, Netherlands
          Amsterdam UMC
        Jun 23, 2023